J&J COVID-19 vaccine shipping to U.S., but new deliveries hinge on regulators
Johnson & Johnson will ship nearly 4 million doses of its newly authorized single-dose COVID-19 vaccine around the United States this week, but a top executive said on Monday that the next round of deliveries is contingent on regulatory approvals at a new plant. Gloria Tso reports.
UP NEXT
UP NEXT
-
India's daily virus cases breach 100,000; mutants, behaviour blamed
Reuters
-
India's daily virus cases breach 100,000; mutants, behaviour blamed
Reuters
-
U.S. puts J&J in charge of plant that botched COVID vaccine, removes AstraZeneca
Reuters
-
U.S. CDC: travel 'low risk' for vaccinated people; not recommending trips
Reuters
-
Russian doctors complete open-heart surgery as tsarist-era hospital burns
Reuters
-
Exclusive: Fauci says U.S. may not need AstraZeneca COVID-19 vaccine
Reuters
-
Pfizer says COVID-19 vaccine safe, effective on adolescents in trial
Reuters
-
U.S., 13 countries concerned WHO COVID-19 origin study was delayed, lacked access -statement
Reuters
-
Data withheld from WHO team probing COVID-19 origins in China - Tedros
Reuters
-
India tells states to get a grip before COVID-19 overwhelms hospitals
Reuters
-
India records 56,211 new cases of the coronavirus
Reuters
-
India's Maharashtra state imposes night curfew after record COVID jump
Reuters
-
U.S. administers nearly 137 million doses of COVID-19 vaccines: CDC
Reuters
-
Special Report: How a coronavirus variant tore through an English island and onto the world stage
Reuters
-
Biden sets goal of 200 million U.S. COVID-19 shots in his first 100 days
Reuters
-
Fauci: AstraZeneca likely to release new statement on its COVID-19 vaccine
Reuters